References
- Greenwell P. Blood group antigens: molecules seeking a function? Glycoconj J 1997;14:159–73.
- Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. J Am Soc Hematol 1997; 89:3077–91.
- Jarolim P,Murray JL, Rubin HL, Coghlan G, Zelinski T. A Thr552→Ile substitution in erythroid band 3 gives rise to the Warrior blood group antigen.Transfusion 1997;37:398–405.
- Jarolim P, Murray JL, Rubin HL, Smart E, Moulds JM. Blood group antigens Rba,Tra,and Wda are located in the third ectoplasmic loop of erythroid band 3. Transfusion 1997;37:607–15.
- Murphy MT, Templeton LJ, Fleming J, Ferguson M, Peterkin M, Fraser RH. Comparison of Fyb status as determined serologically and genetically. Transfus Med 1997;7:135–41.
- Snowden JA, Poole J, Bates AJ,et al.The Rh null phenotype in an English individual: haematological, serological and immunological studies. Clin Lab Haematol 1997;19:143–8.
- Spence WC, Maddalena A, Demars DB, Bick DP. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies. J Reprod Med 1997; 42:353–7.
- Daniels G. Coordinator’s report: antibodies to Lutheran, Kell, Duffy, Kidd, and Jra antigens.Transfus Clin Biol 1997;4:99–103.
- Hadley A, Poole J, Poole G.The clinical significance of anti-G in alloimmunized pregnant women (letter). Transfusion 1997;37:985.
- Janvier D, Veaux S, Benbunan M. Investigation of monoclonal antibodies directed against Fy3, Jra,Lub, Kell or Kell-related antigens.Transfus Clin Biol 1997; 4:107–9.
- Joshi SR. Citrate-dependent auto-antibody causing error in blood grouping.Vox Sang 1997;72:229–32.
- Rasamoelisolo M, Czerwinski M,Bruneau V, Lisowska E, Blanchard D. Fine characterization of a series of new monoclonal antibodies directed against glycophorin A.Vox Sang 1997;72:185–91.
- Reid ME, Halverson GR. Characterization of monoclonal antibodies in section 2B using enzymes and variant red blood cells. Transfus Clin Biol 1997; 4:65–8.
- Sandler SG, Mallory D, Wolfe JS, Byrne P, Lucas DM. Screening with monoclonal anti-FY3 to provide blood for phenotype-matched transfusions for patients with sickle cell disease. Transfusion 1997; 37:393–7.
- Shirey RS, Mirabella DC, Lumadue JA, Ness RM. Differentiation of anti-D, -C, and -G: clinical relevance in alloimmunized pregnancies. Transfusion 1997; 37:493–6.
- Bordin JO, Kelton JG, Warner MN,et al. Maternal immunization to Gov system alloantigens on human platelets.Transfusion 1997;37:823–8.
- Bunce M, Barnardo MC, Procter J, Marsh SG, Vilches C, Welsh KI. High resolution HLA-C typing by PCR-SSP: Identification of allelic frequencies and linkage disequilibria in 604 unrelated UK Caucasoids and a comparison with serology. Tissue Antigens 1997; 50:100–11.
- Bux J, Chapman J.Report on the second international granulocyte serology workshop.Transfusion 1997; 37:977–83.
- Conte R, Cirillo D, Ricci F,Tassi C,Tazzari PL. Platelet transfusion in a patient affected by Glanzmann’s thrombasthenia with antibodies against GPIIb-IIIa. Haematologica 1997;82:73–4.
- Darke C, Street J, Fussell H,et al.A new HLA-B44 variant (B44BO [B*4408]) identified by serology.Tissue Antigens 1997;50:32–7.
- Gelb AB, Leavitt AD. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 1997;37:624–30.
- Suberbielle-Boissel C, Chapuis E,Charron K,Raffoux C. Comparative study of two methods of HLA-DR typing: serology and PCR/dot blood reverse. Transplant Proc 1997;29:2335–6.
- Swanson JL, Pulkrabek S, Scofield TL, Stroncek DF, Key NS. Simultaneous occurrence of post-transfusion purpura due to anti-HPA-Ia and a delayed transfusion reaction due to anti-Jkb (letter). Transfusion 1997;37:449–50.
- Udani M,Rao N, Telen MJ. Leukocyte phenotypic changes in an in vitro model of ABO hemolytic transfusion reaction.Transfusion 1997;37:904–9.
- Ameno S, Ameno K, Kinoshita H, Tanaka N, Ijiri I. Lewis genotyping by the PCR-RFLP method in a Japanese population and its evaluation in forensic analysis. Int J Legal Med 1997;110:232–4.
- Beckers EA, Faas BH, Ligthart P,et al. Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RhD gene. Transfusion 1997;37:616–23.
- Hamlington J, Cunningham J, Mason G, Mueller R, Miller D. Prenatal detection of rhesus D genotype (letter). Lancet 1997;349:540.
- Hengstschlager M, Holzl G,Ulm B, Bernaschek G. Raising the sensitivity of fetal RhD typing and sex determination from maternal blood (letter). J Med Genet 1997;34:350–1.
- Murphy MT, Fraser RH. Detection of Kell blood groups: molecular methods in the diagnostic laboratory. Blood Rev 1997;11:8–15.
- Suzuki K, Iwata M,Tsuji H,et al.A de nova recombination in the ABO blood group gene and evidence for the occurrence of recombination products. Hum Genet 1997;99:454–61.
- Tonn T,Westrup D, Seidl C, Kirchmaier CM, Seifried E. Sensitive determination of the RhD genotype in mixed samples using fluorescence-based polymerase chain reaction.Vox Sang 1997;72:177–81.
- Ashford P. Guidelines for pre-transfusion compatibility procedures (letter).Transfus Med 1997;7:171.
- Beck ML. Coordinator’s report:ABH and other glycoconjugates—serology. Transfus Clin Biol 1997;4: 13–6.
- Burin des Roziers N, Squalli S. Removing IgG antibodies from intact red cells:comparison of acid and EDTA, heat and chloroquine elution methods. Transfusion 1997;37:497–501.
- Fabijanska-Mitek J, Lopienska H, Zupanska B.Gel test application for IgG subclass detection in autoimmune haemolytic anaemia.Vox Sang 1997;72:233–7.
- Knight R. LISS versus other low ionic suspension solutions for red cells (letter). Br J Biomed Sci 1997; 54:74.
- Llopis F, Carbonell-Uberos F, Planelles MD, et al.A monolayer coagulation microplate technique for typing red blood cells.Vox Sang 1997;72:26–30.
- Moncharmont P, Grannoli C, Chirat V, Chalard T.Weak rhesus D (RHI) grouping on the Olympus PK7100 blood grouping system (letter). Transfus Med 1997; 7:66–7.
- Murphy MT, Templeton LJ, Fleming J, Ferguson M, Peterkin M, Fraser RH. Comparison of Fyb status as determined serologically and genetically. Transfus Med 1997;7:135–41.
- Nathalang O, Chuansumrit A, Prayoonwiwat W, Siripoonya P, Sriphaisal T. Comparison between the conventional tube technique and the gel technique in direct antiglobulin tests. Vox Sang 1997;72: 169–71.
- Petty AC, Green CA, Poole J, Daniels GL. Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting. Transfus Med 1997;7:55–62.
- Phillips P, Voak D, Knowles S, et al.An explanation and the clinical significance of the failure of microcolumn tests to detect weak ABO and other antibodies.Tranfus Med 1997;7:47–53.
- Quinn JG, O’Kennedy R, Smyth M, Moulds J, Frame T. Detection of blood group antigens utilising immobilised antibodies and surface plasmon resonance. J Immunol Methods 1997;206:87–96.
- Rouger P, Noizat-Pirenne F,Le Pennec PY.Advances in the use of monoclonal antibodies for blood group testing.Transfus Clin Biol 1997;4:345–9.
- Scott ML,Voak D. Detection of acquired B antigen by monoclonal anti-B blood grouping reagents (letter). Transfusion 1997;37:103. (Note: Three more letters with the same title follow from 103–5.)
- Scott Y, McArdle B, Parker PI. Column agglutination technologies (letter). Br J Biomed Sci 1997;54:153.
- Stoya G, Baumann E, Junker V, Hermann J, Linss W. Flow cytometric analysis of band 3 protein of human erythrocytes.Acta Histochem 1997;99:29–36.
- Yankowitz J,Li S, Weiner CP. Polymerase chain reaction determination of RhC, Rhc, and RhE blood types: an evaluation of accuracy and clinical utility. Am J Obstet Gynecol 1997;176:107–11.
- Bowman J.The management of hemolytic disease in the fetus and newborn. Semin Perinatal 1997;21: 39–44.
- Duguid JK.Antenatal serological testing and prevention of haemolytic disease of the newborn. J Clin Pathol 1997;50:193–6.
- Elasoud K, McClure G, Halliday HL, Dornan JC. Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy. Ulster Med J 1997; 66:62–4.
- Goodrum LA, Saade GR, Belfont MA, Carpenter RJ Jr, Moise KJ Jr.The effect of intrauterine transfusion on fetal bilirubin in red cell alloimmunization. Obstet Gynecol 1997;89:57–60.
- Guervich P,Erina S,Gershon S, Zusman I.The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of the newborn. Hum Antibodies 1997;8:76–89.
- Harding K. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines adequately followed? (letter) Br J Obstet Gynaecol 1997;104:869–70.
- Howard HL, Martlew VJ, McFadyen IR, Clarke CA. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed? Br J Obstet Gynaecol 1997;104:37–41.
- Kumpel BM. Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn. Transfus Clin Biol 1997;4:351–6.
- Porter TF, Silver RM, Jackson GM, Branch DW, Scott JR. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv 1997;52:193–7.
- Wong KF,Tse KT, Lee AW, Mak CS,So CC.Is antenatal antibody screening worthwhile in Chinese? Br J Haematol 1997;97:917–9.
- Cook LS. Nonimmune transfusion reactions: when type-and-cross match aren’t enough. J Intraven Nurs 1997;20:15–22.
- Craig V, Bower JO. Blood administration in perioperative settings.Aorn J 1997;66:133–8.
- Evans CS. Out-of-hospital transfusion. Transfusion 1997;37:756–67.
- 4.Fitzpatrick L, Fitzpatrick T. Blood transfusion—keeping your patient safe.Nursing 1997;27:34–41.
5.Lam HT, Schweitzer SO, Petz L,et al.Effectiveness of a prospective physician self-audit transfusion-monitoring system.Transfusion 1997;37:577–84.
- Legler TJ, Fischer L, Dittman J,et al. Frequency and causes of refractoriness in multiply transfused patients.Ann Hematol 1997;74:185–9.
- Marosszeky S, McDonald S, Sutherland J,et al. Suitability of preadmission blood sample for pretransfusion testing in elective surgery. Transfusion 1997;37:910–2.
- Renton MC, McClelland DB, Sinclair CJ. Use of blood products in cardiac surgery. Perfusion 1997;12: 157–62.
- Vietor HE, Bolk J, Vreugdenhil GR, Kanhai HH, van den Elsen PJ, Brand A.Alterations in cord blood leukocyte subsets of patients with severe hemolytic disease after intrauterine transfusion therapy. J Pediatr 1997;130:718–24.
- Vietor HE, Hawes GE, van den Dever C. Intrauterine transfusions affect fetal T-cell immunity. Blood 1997; 90:2492–501.
- Wenz B,Mercuriali F,AuBuchon JP. Practical methods to improve transfusion safety by using novel blood unit and patient identification systems. Am J Clin Pathol 1997;107:S12–6.
- Barker RN,Shen CR, Mazza G,Perry FE, Hall AM,Elson CJ.T-cell subsets in autoimmune haemolytic anaemia. Biochem Soc Trans 1997;25(Suppl):312S.
- Frost AE. Donor criteria and evaluation. Clin Chest Med 1997;18:231–7.
- Gluckman E, Rocha V, Bayer-Chammard A,et al. Outcome of cord-blood transplantation from related and unrelated donors (abstract).N Engl J Med 1997; 337:373.
- Hortin GL, Lok HT, Huang ST. Progress toward preparation of universal donor red cells.Artif Cells Blood Substit Immobil Biotechnol 1997;25:487–91.
- Judd WJ,Davenport R.On the high probability that a perceived lack of value of obtaining a p value will be detrimental to patient care (letter).Transfusion 1997; 37:877.
- King KE, Shirey RS, Lankiewicz MW,Young-Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients’ red cells.Transfusion 1997;37:357–61.
- Moulds MK, Spruell P, Moulds JJ. Characterization of selected GPA, GPA and GPB, and/or Band 3 MAbs. Transfus Clin Biol 1997;4:89.
- Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome.Transfusion 1997;37:382–92.
- Pieters H, Brand CE, Badenhorst PN, Hendricks ML. Immunoglobulin G sub-class concentrations in South African adults: ethic differences and reference ranges. Br J Biomed Sci 1997;54:104–9.
- Reid ME, Lisowska E, Blanchard D. Coordinator’s report:glycophorin/band 3 and associated antigens. Transfus Clin Biol 1997;4:57–64.
- Robak T, Blasinska-Morawiec M, Krykowski E, Hellmann A, Konopka L. Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine).Eur J Haematol 1997;58:109–13.
- Russell JA, Desai S, Herbut B,et al. Partially mismatched blood cell transplants for high-risk hematologic malignancy. Bone Marrow Transplant 1997;19: 861–6.
- Safwenberg J, Hogman CF, Cassemar B. Computerized delivery control—a useful and safe complement to the type and screen compatibility testing.Vox Sang 1997;72:162–8.
- Steegmann JL, Pinilla I, Requena MJ,et al.The direct antiglobulin test is frequently positive in chronic myeloid leukemia patients treated with interferonalpha (letter).Transfusion 1997;37:446–7.
- Win N, Islam SI, Peterkin MA, Walker ID. Positive direct antiglobulin test due to antiphospholipid antibodies in normal healthy blood donors. Vox Sang 1997;72:182–4.
- Yawata Y. Hemolytic anemia—recent findings—with special reference to erythrocyte membrane abnormalities. Nippon Naika Gakkai Zasski 1997;86: 481–90.